Laboratorios Farmaceuticos Rovi, S.A.
LABFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.44B
Close$
$56.15
16.4% downside
Current Fair Value
16.4% downsideOvervalued by 16.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.44 Billion |
|---|---|
| Enterprise Value | $3.44 Billion |
| Annual dividend | $1.10 |
| Dividend yield | 1.53% |
| Earnings per Share | $2.75 |
| Beta | 0.24 |
| Outstanding Shares | 51,149,498 |
Return
| Return on Equity | 26.43% |
|---|---|
| Return on Assets | 16.43% |
| Return on Invested Capital | 27.34% |
Valuation & Multiples
| P/E Ratio | 17.28 |
|---|---|
| PEG | 7.01 |
| Price to Sales | 4.48 |
| Price to Book Ratio | 4.8 |
| Enterprise Value to Revenue | 4.45 |
| Enterprise Value to EBIT | 14.8 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$203.13 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$265.10 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Laboratorios Farmaceuticos Rovi, S.A.
2,232 employees
CEO: Juan Lopez-Belmonte Encina
Laboratorios Farmacéuticos Rovi, S.A. is a Spanish pharmaceutical enterprise that specializes in the research, development, manufacturing, and global commercialization of its own medicinal products. The company's operations span Spain, t...